Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera. Yasugi M, Nakagama Y, Kaku N, Nitahara Y, et al. Vaccine 2023 Sep 4:S0264-410X(23)01040-X. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Yasugi M, Nakagama Y, Kaku N, Nitahara Y, et al. Characteristics of epitope dominance pattern and cross-variant neutralisation in 16 SARS-CoV-2 mRNA vaccine sera. Vaccine 2023 Sep 4:S0264-410X(23)01040-X. doi: 10.1016/j.vaccine.2023.
PMID: 37673717